PL3954360T3 - Preparat farmaceutyczny węglowodanów do zastosowania terapeutycznego - Google Patents

Preparat farmaceutyczny węglowodanów do zastosowania terapeutycznego

Info

Publication number: PL3954360T3
Authority: PL; Poland
Prior art keywords: pharmaceutical preparation; therapeutic use; carbohydrate; carbohydrate pharmaceutical; therapeutic
Prior art date: 2013-09-16

Application number

PL21185152.2T

Other languages

English (en)

Inventor

Agnes RAFALKO

Tatyana CHERNENKO

Original Assignee

Glycomine, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-09-16

Filing date

2014-09-16

Publication date

2025-07-07

2014-09-16 Application filed by Glycomine, Inc. filed Critical Glycomine, Inc.

2025-07-07 Publication of PL3954360T3 publication Critical patent/PL3954360T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dispersion Chemistry (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

PL21185152.2T 2013-09-16 2014-09-16 Preparat farmaceutyczny węglowodanów do zastosowania terapeutycznego PL3954360T3 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201361878591P	2013-09-16	2013-09-16

Publications (1)

Publication Number	Publication Date
PL3954360T3 true PL3954360T3 (pl)	2025-07-07

Family

ID=52813726

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL14851464T PL3046537T3 (pl)	2013-09-16	2014-09-16	Preparat farmaceutyczny węglowodanów do zastosowania terapeutycznego
PL21185152.2T PL3954360T3 (pl)	2013-09-16	2014-09-16	Preparat farmaceutyczny węglowodanów do zastosowania terapeutycznego

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL14851464T PL3046537T3 (pl)	2013-09-16	2014-09-16	Preparat farmaceutyczny węglowodanów do zastosowania terapeutycznego

Country Status (15)

Country	Link
US (6)	US20160228364A1 (pl)
EP (3)	EP3046537B1 (pl)
CY (1)	CY1125361T1 (pl)
DK (2)	DK3954360T3 (pl)
ES (2)	ES2892314T3 (pl)
FI (1)	FI3954360T3 (pl)
HR (2)	HRP20250522T1 (pl)
HU (2)	HUE071419T2 (pl)
LT (2)	LT3046537T (pl)
PL (2)	PL3046537T3 (pl)
PT (2)	PT3954360T (pl)
RS (2)	RS62641B1 (pl)
SI (2)	SI3954360T1 (pl)
SM (2)	SMT202500160T1 (pl)
WO (1)	WO2015053910A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA202192663A1 (ru) *	2019-03-29	2022-03-01	Глайкомайн, Инк.	Липосомальные препараты и способы их применения и получения
US11058637B1 (en) *	2020-11-25	2021-07-13	King Abdulaziz University	Surface-modified emulsomes for intranasal delivery of drugs
AU2023272874A1 (en) *	2022-05-18	2024-11-28	Glycomine, Inc.	Continuous flow methods for producing mannose-1-phosphate, polymorphs of mannose-1-phosphate, and compositions and uses related thereto
WO2025184395A1 (en) *	2024-02-29	2025-09-04	Glycomine, Inc.	Methods of treating congenital disorders of glycosylation (cdg) and ataxia in subjects suffering from cdg

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5013556A (en) *	1989-10-20	1991-05-07	Liposome Technology, Inc.	Liposomes with enhanced circulation time
US7189705B2 (en) *	2000-04-20	2007-03-13	The University Of British Columbia	Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
US7011845B2 (en) *	2000-05-09	2006-03-14	Mcp Hahnemann University	β-glucans encapsulated in liposomes
WO2004103510A2 (en) *	2003-05-14	2004-12-02	The Regents Of The University Of Colorado	Methods and apparatus using electrostatic atomization to form liquid vesicles
FR2897779B1 (fr)	2006-02-24	2009-04-17	Orphan Europ Sarl	Manossyl-1 phosphates, procede de preparation et utilisation en therapeutique, notamment vis-a-vis dy syndrome cdg-la
WO2009118658A2 (en)	2008-03-26	2009-10-01	University Of Oxford	Endoplasmic reticulum targeting liposomes
US20120135064A1 (en) *	2009-05-27	2012-05-31	Northeastern University	Conjugated nanodelivery vehicles
CA3009891C (en)	2009-12-23	2020-09-15	Novartis Ag	Lipids, lipid compositions, and methods of using them
WO2011116355A2 (en)	2010-03-19	2011-09-22	Sanford-Burnham Medical Research Institute	Benzoisothiazolones as inhibitors of phosphomannose isomerase
CA2807141C (en) *	2010-07-31	2019-02-26	The Scripps Research Institute	Compositions and methods for inducing immune tolerance

2014
- 2014-09-16 DK DK21185152.2T patent/DK3954360T3/da active
- 2014-09-16 RS RS20211212A patent/RS62641B1/sr unknown
- 2014-09-16 SM SM20250160T patent/SMT202500160T1/it unknown
- 2014-09-16 HR HRP20250522TT patent/HRP20250522T1/hr unknown
- 2014-09-16 WO PCT/US2014/055921 patent/WO2015053910A2/en not_active Ceased
- 2014-09-16 HU HUE21185152A patent/HUE071419T2/hu unknown
- 2014-09-16 EP EP14851464.9A patent/EP3046537B1/en active Active
- 2014-09-16 EP EP21185152.2A patent/EP3954360B1/en active Active
- 2014-09-16 SI SI201432105T patent/SI3954360T1/sl unknown
- 2014-09-16 PT PT211851522T patent/PT3954360T/pt unknown
- 2014-09-16 FI FIEP21185152.2T patent/FI3954360T3/fi active
- 2014-09-16 DK DK14851464.9T patent/DK3046537T3/da active
- 2014-09-16 ES ES14851464T patent/ES2892314T3/es active Active
- 2014-09-16 RS RS20250391A patent/RS66755B1/sr unknown
- 2014-09-16 HU HUE14851464A patent/HUE056624T2/hu unknown
- 2014-09-16 ES ES21185152T patent/ES3026657T3/es active Active
- 2014-09-16 EP EP25157136.0A patent/EP4563152A3/en active Pending
- 2014-09-16 SM SM20210570T patent/SMT202100570T1/it unknown
- 2014-09-16 SI SI201431883T patent/SI3046537T1/sl unknown
- 2014-09-16 HR HRP20211564TT patent/HRP20211564T1/hr unknown
- 2014-09-16 US US15/022,194 patent/US20160228364A1/en not_active Abandoned
- 2014-09-16 LT LTEPPCT/US2014/055921T patent/LT3046537T/lt unknown
- 2014-09-16 PL PL14851464T patent/PL3046537T3/pl unknown
- 2014-09-16 LT LTEP21185152.2T patent/LT3954360T/lt unknown
- 2014-09-16 PT PT14851464T patent/PT3046537T/pt unknown
- 2014-09-16 PL PL21185152.2T patent/PL3954360T3/pl unknown
2017
- 2017-10-19 US US15/788,591 patent/US10449149B2/en active Active
2019
- 2019-09-11 US US16/568,098 patent/US11045419B2/en active Active
2021
- 2021-05-21 US US17/327,241 patent/US20220110871A1/en not_active Abandoned
- 2021-10-05 CY CY20211100863T patent/CY1125361T1/el unknown
2023
- 2023-03-30 US US18/193,328 patent/US20240082155A1/en not_active Abandoned
2024
- 2024-07-18 US US18/777,142 patent/US20250186345A1/en active Pending

Also Published As

Publication number	Publication date
US20240082155A1 (en)	2024-03-14
EP3046537A2 (en)	2016-07-27
US11045419B2 (en)	2021-06-29
EP4563152A3 (en)	2025-11-19
EP3954360A2 (en)	2022-02-16
EP4563152A2 (en)	2025-06-04
ES3026657T3 (en)	2025-06-11
WO2015053910A2 (en)	2015-04-16
EP3954360A3 (en)	2022-06-01
FI3954360T3 (fi)	2025-05-15
HRP20211564T1 (hr)	2022-01-21
EP3046537A4 (en)	2017-04-19
WO2015053910A3 (en)	2015-06-18
PL3046537T3 (pl)	2022-01-31
PT3954360T (pt)	2025-04-30
SMT202100570T1 (it)	2022-01-10
HUE071419T2 (hu)	2025-08-28
PT3046537T (pt)	2021-10-07
US20160228364A1 (en)	2016-08-11
HRP20250522T1 (hr)	2025-06-20
ES2892314T3 (es)	2022-02-03
SI3046537T1 (sl)	2022-01-31
CY1125361T1 (el)	2023-03-24
EP3046537B1 (en)	2021-07-14
US10449149B2 (en)	2019-10-22
US20220110871A1 (en)	2022-04-14
SI3954360T1 (sl)	2025-06-30
RS62641B1 (sr)	2021-12-31
EP3954360B1 (en)	2025-02-12
US20200246266A1 (en)	2020-08-06
DK3046537T3 (da)	2021-10-11
LT3954360T (lt)	2025-05-12
US20180036239A1 (en)	2018-02-08
DK3954360T3 (da)	2025-05-12
LT3046537T (lt)	2021-12-10
US20250186345A1 (en)	2025-06-12
HUE056624T2 (hu)	2022-02-28
RS66755B1 (sr)	2025-05-30
SMT202500160T1 (it)	2025-05-12

Publication	Publication Date	Title
FR21C1059I2 (fr)	2022-12-02	Compositions pharmaceutiques
DK2983721T4 (da)	2021-02-01	Terapeutiske indgivelsesvesikler
DK3062849T3 (da)	2023-09-25	Medikamentadministrationsanordning
HUE046964T2 (hu)	2020-04-28	Kombinált gyógyászati készítmény
EP2968894A4 (en)	2016-12-21	MEDICAL CONNECTOR
DK3639872T3 (da)	2023-04-11	Lægemiddeladministrationsanordning
EP3821931C0 (en)	2025-10-08	ORONASAL PATIENT INTERFACE
EP2922514A4 (en)	2016-01-13	BI-RADIAL PATIENT INTERFACE
BR112016009485A2 (pt)	2017-08-01	Inalador de medicamento
PT3089754T (pt)	2021-07-23	Formulações de vacina de dose única
EP2953618A4 (en)	2016-11-30	MANIPULATION-SAFE PHARMACEUTICAL FORMULATIONS
IL240797B (en)	2022-01-01	Oral formulations of deferasirox
DK2767269T3 (da)	2019-05-06	Terapeutisk anordning
LT3563837T (lt)	2021-12-27	Terapija bakteriofagu
DK3357522T3 (da)	2020-01-27	Coatet medicinsk genstand til lægemiddelsfrigivelse
DK3079655T3 (da)	2019-06-11	Inhalerbare lægemidler
DK3071265T3 (da)	2023-07-24	Fjederassisteret lægemiddeladministrationsanordning
DK2964193T3 (da)	2020-03-16	Lægemidler til oral indgivelse
DK3079667T3 (da)	2019-09-09	Farmaceutiske doseringsformer
DK3003401T3 (da)	2020-04-06	Farmaceutisk præparat
EP2988734C0 (en)	2024-12-25	FORMULATION OF A HARD CAPSULE
PL3954360T3 (pl)	2025-07-07	Preparat farmaceutyczny węglowodanów do zastosowania terapeutycznego
DK2897588T3 (da)	2019-08-12	Inhalerbart lægemiddel
EP3043648C0 (en)	2023-09-20	PHARMACEUTICAL COMPOSITIONS OF BENDAMUSTINE
DK2983747T3 (da)	2020-02-24	Lægemiddelindgivelsesindretning